California State Teachers Retirement System Biotechnology

California State Teachers Retirement System

$84.1 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
VCEL Vericel Corp	$2.49B	$1.85 Million 0.0% of portfolio	43,843	Q3 2024 Reduced 2.89%
NTLA Intellia Therapeutics, Inc.	$1.15B	$1.79 Million 0.0% of portfolio	87,042	Q3 2024 Reduced 3.13%
IOVA Iovance Biotherapeutics, Inc.	$1.36B	$1.78 Million 0.0% of portfolio	189,467	Q3 2024 Reduced 2.93%
SWTX Spring Works Therapeutics, Inc.	$2.28B	$1.71 Million 0.0% of portfolio	53,521	Q3 2024 Reduced 2.76%
LGND Ligand Pharmaceuticals Inc	$1.95B	$1.7 Million 0.0% of portfolio	16,927	Q3 2024 Added 3.02%
BEAM Beam Therapeutics Inc.	$1.85B	$1.63 Million 0.0% of portfolio	66,660	Q3 2024 Reduced 2.39%
MNKD Mannkind Corp	$1.81B	$1.61 Million 0.0% of portfolio	257,102	Q3 2024 Reduced 2.67%
KROS Keros Therapeutics, Inc.	$1.55B	$1.59 Million 0.0% of portfolio	27,354	Q3 2024 Reduced 3.18%
ACAD Acadia Pharmaceuticals Inc	$2.75B	$1.57 Million 0.0% of portfolio	102,234	Q3 2024 Reduced 3.17%
KYMR Kymera Therapeutics, Inc.	$2.51B	$1.55 Million 0.0% of portfolio	32,708	Q3 2024 Reduced 26.82%
ARDX Ardelyx, Inc.	$707M	$1.52 Million 0.0% of portfolio	221,279	Q3 2024 Reduced 2.67%
NVAX Novavax Inc	$565M	$1.52 Million 0.0% of portfolio	120,633	Q3 2024 Reduced 2.84%
VERA Vera Therapeutics, Inc.	$1.33B	$1.5 Million 0.0% of portfolio	33,891	Q3 2024 Reduced 2.78%
SNDX Syndax Pharmaceuticals Inc	$950M	$1.4 Million 0.0% of portfolio	72,761	Q3 2024 Reduced 3.43%
AKRO Akero Therapeutics, Inc.	$1.38B	$1.35 Million 0.0% of portfolio	47,208	Q3 2024 Reduced 8.9%
BCRX Biocryst Pharmaceuticals Inc	$1.39B	$1.35 Million 0.0% of portfolio	177,253	Q3 2024 Reduced 3.07%
IMVT Immunovant, Inc.	$3.55B	$1.35 Million 0.0% of portfolio	48,909	Q3 2024 Reduced 2.64%
MIRM Mirum Pharmaceuticals, Inc.	$1.7B	$1.32 Million 0.0% of portfolio	33,729	Q3 2024 Added 3.29%
SAVA Cassava Sciences Inc	$1.05B	$1.26 Million 0.0% of portfolio	42,734	Q3 2024 Added 6.5%
NRIX Nurix Therapeutics, Inc.	$1.27B	$1.18 Million 0.0% of portfolio	52,454	Q3 2024 Added 4.96%
HRMY Harmony Biosciences Holdings, Inc.	$1.95B	$1.18 Million 0.0% of portfolio	29,458	Q3 2024 Reduced 3.1%
RXRX Recursion Pharmaceuticals, Inc.	$1.25B	$1.17 Million 0.0% of portfolio	177,086	Q3 2024 Added 4.77%
ARVN Arvinas, Inc.	$1.33B	$1.15 Million 0.0% of portfolio	46,516	Q3 2024 Reduced 2.9%
RCKT Rocket Pharmaceuticals, Inc.	$1.12B	$1.11 Million 0.0% of portfolio	60,293	Q3 2024 Reduced 2.94%
XNCR Xencor Inc	$1.4B	$1.06 Million 0.0% of portfolio	52,754	Q3 2024 Reduced 2.65%
VRDN Viridian Therapeutics, Inc.\De	$863M	$1.05 Million 0.0% of portfolio	46,366	Q3 2024 Reduced 1.82%
LBPH Longboard Pharmaceuticals, Inc.	$812M	$1.04 Million 0.0% of portfolio	31,195	Q3 2024 Added 10.66%
INVA Innoviva, Inc.	$1.34B	$1.02 Million 0.0% of portfolio	53,081	Q3 2024 Reduced 4.36%
EWTX Edgewise Therapeutics, Inc.	$2.08B	$1.01 Million 0.0% of portfolio	37,927	Q3 2024 Reduced 3.02%
MLTX Moon Lake Immunotherapeutics	$1.91B	$968,000 0.0% of portfolio	19,213	Q3 2024 Added 34.88%
AUPH Aurinia Pharmaceuticals Inc.	$1.18B	$941,000 0.0% of portfolio	128,415	Q3 2024 Reduced 4.69%
ARQT Arcutis Biotherapeutics, Inc.	$598M	$917,000 0.0% of portfolio	98,654	Q3 2024 Reduced 2.61%
JANX Janux Therapeutics, Inc.	$2.13B	$915,000 0.0% of portfolio	20,160	Q3 2024 Reduced 2.79%
TVTX Travere Therapeutics, Inc.	$1.19B	$911,000 0.0% of portfolio	65,151	Q3 2024 Reduced 3.29%
MRVI Maravai Lifesciences Holdings, Inc.	$684M	$885,000 0.0% of portfolio	106,574	Q3 2024 Reduced 2.96%
KURA Kura Oncology, Inc.	$1.1B	$883,000 0.0% of portfolio	45,206	Q3 2024 Reduced 9.71%
OCUL Ocular Therapeutix, Inc	$764M	$863,000 0.0% of portfolio	99,281	Q3 2024 Reduced 2.74%
TARS Tarsus Pharmaceuticals, Inc.	$1.24B	$847,000 0.0% of portfolio	25,754	Q3 2024 Added 5.5%
DAWN Day One Biopharmaceuticals, Inc.	$1.05B	$766,000 0.0% of portfolio	55,061	Q3 2024 Added 16.21%
RCUS Arcus Biosciences, Inc.	$1.14B	$727,000 0.0% of portfolio	47,610	Q3 2024 Reduced 3.29%
CDMO Avid Bioservices, Inc.	$742M	$682,000 0.0% of portfolio	60,012	Q3 2024 Reduced 2.98%
VIR Vir Biotechnology, Inc.	$1.15B	$671,000 0.0% of portfolio	89,630	Q3 2024 Reduced 2.61%
MDXG Mimedx Group, Inc.	$1.05B	$660,000 0.0% of portfolio	111,680	Q3 2024 Reduced 3.01%
COGT Cogent Biosciences, Inc.	$635M	$657,000 0.0% of portfolio	60,905	Q3 2024 Reduced 3.24%
PHAT Phathom Pharmaceuticals, Inc.	$356M	$637,000 0.0% of portfolio	35,261	Q3 2024 Added 21.38%
WVE Wave Life Sciences Ltd.	$1.3B	$615,000 0.0% of portfolio	75,022	Q3 2024 Reduced 3.53%
CGEM Cullinan Oncology, Inc.	$698M	$610,000 0.0% of portfolio	36,479	Q3 2024 Reduced 0.48%
RLAY Relay Therapeutics, Inc.	$673M	$584,000 0.0% of portfolio	82,527	Q3 2024 Reduced 2.26%
PRTA Prothena Corp Public LTD CO	$755M	$561,000 0.0% of portfolio	33,562	Q3 2024 Reduced 3.47%
IMNM Immunome Inc.	$130M	$551,000 0.0% of portfolio	37,753	Q3 2024 Reduced 2.85%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.